GlassScriptPhysician profile
Robert W Perry
NPI 1992787246
$2,932.76
in general payments reported to CMS, 2019-2025
37 companies · $833 in 2025
The $833 reported for 2025 was more than what 82% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.06 · 2022: $450 · 2023: $803 · 2024: $809 · 2025: $833.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,444.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $333.67 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $277.99 | 2022-2025 | Keytruda, Lynparza |
| Astrazeneca Pharmaceuticals LP | $247.42 | 2022-2025 | Lynparza |
| Janssen Biotech, INC. | $224.00 | 2022-2025 | Darzalex, Talvey, Tecvayli |
| Bayer Healthcare Pharmaceuticals INC. | $206.81 | 2022-2025 | |
| Eisai INC. | $161.99 | 2022-2025 | |
| Incyte Corporation | $150.82 | 2023-2025 | Jakafi, Monjuvi |
| Genentech USA, INC. | $126.36 | 2023-2025 | Tecentriq, Alecensa, Polivy |
| Amgen INC. | $98.86 | 2022-2023 | Lumakras, Kyprolis, Nplate |
| Daiichi Sankyo INC. | $89.10 | 2024-2025 | Enhertu, Datroway |
| Takeda Pharmaceuticals U.S.A., INC. | $86.28 | 2023-2025 | Iclusig, Fruzaqla, Ninlaro |
| Integra Lifesciences Corporation | $61.31 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Adaptive Biotechnologies Corporation | $60.19 | 2024-2025 | Clonoseq |
| Jazz Pharmaceuticals INC. | $57.06 | 2022-2025 | |
| Genzyme Corporation | $51.05 | 2022-2023 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.